Mycobacterium Citations List: March 2024

Literature Citations

1. Unravelling the Potential of Triflusal as an anti-TB Repurposed Drug by Targeting Replication Protein DciA. Ali, W., S. Jamal, R. Gangwar, F. Ahmed, I. Pahuja, R. Sharma, V. Prakash Dwivedi, M. Agarwal, and S. Grover. Microbes and Infection, 2024. 26(3): 105284. PMID[38145750].
[PubMed]. TB_03_2024.

2. Unveiling the Antimicrobial and Larvicidal Potential of Butyrolactones and Orsellinic acid Derivatives from the Morus alba-derived Fungus Aspergillus terreus via Integrated in Vitro and in Silico Approaches. Amr, K., A.M. Elissawy, N. Ibrahim, M.S. Elnaggar, I.M. Fawzy, and A.N.B. Singab. Chemistry & Biodiversity, 2024. 21(3): e202301900. PMID[38282171].
[PubMed]. TB_03_2024.

3. In Vitro Antibacterial Activity of Microbial Natural Products against Bacterial Pathogens of Veterinary and Zoonotic Relevance. Barth, S.A., D. Preussger, J. Pietschmann, A.T. Feßler, M. Heller, W. Herbst, C. Schnee, S. Schwarz, F. Kloss, C. Berens, and C. Menge. Antibiotics, 2024. 13(2): 135. PMID[38391521]. PMCID[PMC10886079].
[PubMed]. TB_03_2024.

4. Identification of Essential Oils with Strong Activity against Stationary Phase Mycobacterium abscessus. Cao, D., X. Jiang, T. Wu, Y. Xiang, J. Liu, Z. Li, X. Yuan, K. Bi, X. Dong, T. Tønjum, K. Xu, and Y. Zhang. Heliyon, 2024. 10(5): e27073. PMID[38463856]. PMCID[PMC10920374]. [PubMed]. TB_03_2024.

5. Discovery of 2,9-Diaryl-6-carbamoylpurines as a Novel Class of Antitubercular Agents. Correia, C., A.C. Leite, A.G. Fraga, M.F. Proença, J. Pedrosa, and M.A. Carvalho. European Journal of Medicinal Chemistry, 2024. 268: 116297. PMID[38458108].
[PubMed]. TB_03_2024.

6. Investigation of the Inhibition of Respiratory Bacterial Pathogens and HIV1 Enzymes by Twenty-one South African Mushroom Species. Didloff, J., G.J. Boukes, M.V. Venter, B. Viljoen, M.C. Lee, C. Blom, R.A. Dwyer, and S. Govender. South African Journal of Botany, 2024. 166: p. 375-385. ISI[001173597700001].
[WOS]. TB_03_2024.

7. Combined Antimicrobial Action of Streptomycin and Terpenes against Atypical Mycobacteria Isolated from Fish. Guz, L., K. Puk, D. Szwajgier, and A. Pastuszka. Polish Journal of Veterinary Science, 2024. 27(1): p. 135-138. PMID[38511650].
[PubMed]. TB_03_2024.

8. Synthesis and Anti-mycobacterium Activity of Some New N-Rich Heterocyclic Derivatives and Their Molecular Docking, and DFT Studies. Hegde, R., I. Pushpavathi, T. Venkatesh, O. Nagaraja, and S.R. Kumar. Russian Journal of Bioorganic Chemistry, 2024. 50(1): p. 147-161. ISI[001161236800016].
[WOS]. TB_03_2024.

9. Endophytic Streptomyces Sp. MSARE05 Isolated from Roots of Peanut Plant Produces a Novel Antimicrobial Compound. Islam, M.M., S. Saha, P. Sahoo, and S. Mandal. Journal of Applied Microbiology, 2024. 135(3): lxae051. PMID[38419296].
[PubMed]. TB_03_2024.

10. Study on the anti-Mycobacterium marinum Activity of a Series of Marine-derived 14-membered Resorcylic acid Lactone Derivatives. Jing, Q.Q., J.N. Yin, Y.J. Cheng, Q. Zhang, X.Z. Cao, W.F. Xu, C.L. Shao, and M.Y. Wei. Marine Drugs, 2024. 22(3): 135. PMID[38535476]. PMCID[PMC10972006].
[PubMed]. TB_03_2024.

11. Homo-BacPROTAC-induced Degradation of ClpC1 as a Strategy against Drug-resistant Mycobacteria. Junk, L., V.M. Schmiedel, S. Guha, K. Fischel, P. Greb, K. Vill, V. Krisilia, L. van Geelen, K. Rumpel, P. Kaur, R.V. Krishnamurthy, S. Narayanan, R.K. Shandil, M. Singh, C. Kofink, A. Mantoulidis, P. Biber, G. Gmaschitz, U. Kazmaier, A. Meinhart, J. Leodolter, D. Hoi, S. Junker, F.E. Morreale, T. Clausen, R. Kalscheuer, H. Weinstabl, and G. Boehmelt. Nature Communications, 2024. 15(1): 2005. PMID[38443338]. PMCID[PMC10914731].
[PubMed]. TB_03_2024.

12. Identification of New Anti-mycobacterial Agents Based on Quinoline-Isatin Hybrids Targeting Enoyl Acyl carrier protein reductase (InhA). Khaleel, E.F., A. Sabt, M. Korycka-Machala, R.M. Badi, N.T. Son, N.X. Ha, M.F. Hamissa, A.E. Elsawi, E.B. Elkaeed, B. Dziadek, W.M. Eldehna, and J. Dziadek. Bioorganic Chemistry, 2024. 144: 107138. PMID[38262087].
[PubMed]. TB_03_2024.

13. Design, Synthesis and Biological Evaluation of Novel Pyrido-[2,3-d]-pyrimidin-2-amine Analogues as Antimycobacterial Agents. Kumar, B.V.S., Y.M. Khetmalis, K.S. Chaitanya, A. Chandu, G. Shetye, R. Ma, S. Murugesan, S.G. Franzblau, and K. Sekhar. Journal of Molecular Structure, 2024. 1303: 137600. ISI[001177697700001].
[WOS]. TB_03_2024.

14. Design, Synthesis, Characterization, and Biological Evaluation of Novel Pyrazine-1,3,4-oxadiazole/[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine Hybrids as Potent Antimycobacterial Agents. Kumar, S., P. Dinesha, D. Udayakumar, V.P. Shetty, and V.K. Deekshit. Journal of Molecular Structure, 2024. 1304: 137657. ISI[001175777600001].
[WOS]. TB_03_2024.

15. Synthesis and In Vitro Metabolic Stability of Sterically Shielded Antimycobacterial Phenylalanine Amides. Lang, M., U.S. Ganapathy, L. Mann, R.W. Seidel, R. Goddard, F. Erdmann, T. Dick, and A. Richter. ChemMedChem, 2024. 19(6): e202300593. PMID[38329388]. PMCID[PMC10965373].
[PubMed]. TB_03_2024.

16. Two New Naturally Dimers Constituent from Indonesian Sesbania Grandiflora Plant and Their Bioactivity. Noviany, N., H. Osman, S. Mohamad, B. Irawan, W.A. Kusuma, J.F. Suwandi, S. Hadi, and N.S. Aminah. Pure and Applied Chemistry, 2024. ISI[001166627800001].
[WOS]. TB_03_2024.

17. Synthesis and Antitubercular Activity of New 5-Alkynyl Derivatives of 2-Thiouridine. Platonova, Y.B., V.A. Kirillova, A.N. Volov, and S.V. Savilov. Russian Journal of Organic Chemistry, 2023. 59(12): p. 2083-2091. ISI[001169525600022].
[WOS]. TB_03_2024.

18. Synthesis, Biological Evaluation and Molecular Docking Study of Pyrimidine Linked Thiazolidinedione Derivatives as Potential Antimicrobial and Antitubercular Agents. Raghu, M.S., C.B. Pradeep Kumar, K. Yogesh Kumar, M.K. Prashanth, F. Alharethy, and B.H. Jeon. Bioorganic & Medicinal Chemistry Letters, 2024. 103: 129707. PMID[38492608].
[PubMed]. TB_03_2024.

19. Development and Evaluation of New Oxindole Derivatives as Potential Anti-tubercular Agents. Velavalapalli, V.M., G.S. Kumar, N.K. Katari, and R. Gundla. Journal of Molecular Structure, 2024. 1304: 137649. ISI[001177489900001].
[WOS]. TB_03_2024.

Patent Citations

20. Preparation of 1-Substituted Benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate Derivatives as Antitubercular Agents. Venugopala, K.N., P.K. Deb, M. Pillay, S. Chandrashekharappa, M.A. Morsy, B.E. Aldhubiab, M. Attimarad, A.B. Nair, N. Sreeharsha, V. Uppar, R.P. Mailavaram, and B. Padmashali. Patent. 2024. US2023-236237 11919900: 16pp.
[Patent]. TB_03_2024.

21. Preparation of 1-2(-(Substituted phenyl)-2-oxoethyl)-4-(isopropoxycarbonyl)pyridin-1-ium Bromides as Anti-tubercular Agents. Venugopala, K.N., P.K. Deb, M. Pillay, M.A. Morsy, B. Aldhubiab, and S. Chandrashekharappa. Patent. 2024. US2023-377542 11919860: 13pp.
[Patent]. TB_03_2024.

22. Substituted 7-Methylquinoline Derivatives as Antitubercular Agents. Venugopala, K.N., P.K. Deb, M. Pillay, V. Uppar, M.A. Morsy, B. Aldhubiab, M. Attimarad, A.B. Nair, N. Sreeharsha, S. Chandrashekharappa, and B. Padmashali. Patent. 2024. US2023-240256 11926627: 11pp.
[Patent]. TB_03_2024.

23. Preparation of Substituted 1,4-Dihydropyrimidines as Antitubercular Agents. Venugopala, K.N., M.A. Morsy, P.K. Deb, M. Pillay, R. Durai, M.R.M. Bhojegowd, D. Thirumalai, and V. Mohanlall. Patent. 2024. US2023-234538 11932609: 16pp.
[Patent]. TB_03_2024.